Literature DB >> 6733693

Essential myoclonus: response to anticholinergic therapy.

R C Duvoisin.   

Abstract

Benztropine mesylate (Cogentin) in total daily dosages of 4 to 9 mg markedly suppressed the involuntary jerking movements in three patients (a brother and sister and a third apparently sporadic case) with essential myoclonus.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6733693

Source DB:  PubMed          Journal:  Clin Neuropharmacol        ISSN: 0362-5664            Impact factor:   1.592


  2 in total

1.  Myoclonus.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  2000-05       Impact factor: 3.598

2.  A patient with genetically confirmed myoclonus-dystonia responded to anticholinergic treatment and improved spontaneously.

Authors:  Jae Hyeok Lee; Chul Hyoung Lyoo; Myung Sik Lee
Journal:  J Clin Neurol       Date:  2011-12-29       Impact factor: 3.077

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.